LIDOCAINE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of one package of LIDOCAINE HYDROCHLORIDE INJECTION with NSN 6505016140068 and NDC 63323-0485-27. The total contract value is $22.25, with a fixed unit price of $22.2500 for a quantity of 1.000 PG, delivered FOB destination to the U.S. Navy Fleet Post Office address USNS PILLALAU T AKR 304, UNIT 100477 BOX 1, FPO AP 96675, US. The delivery is due on July 20, 2026, with inspection and acceptance occurring at the destination by the Government. The awardee is certified as a small business, small disadvantaged business, and women-owned small business, triggering compliance obligations under FAR Part 19 including potential subcontracting plan requirements and ongoing verification through SAM.gov. Packaging and marking must include the basic contract number SPE2DX-25-D-9822 and delivery order number SPE2D2-26-F-3073, with no additional preservation, packaging, or barcoding standards specified. Payment is to be processed by DEF FIN AND ACCOUNTING SVC, BSM, using accounting code BX, TAS 97X4930, and ACRN 5CBX 001 2620 S33189. The contracting officer is LISA QUINN, contacted via LISA.QUINN@DLA.MIL, with administrative support provided by JAYNE DO at DLA Troop Support. The acquisition follows a Lowest Price Technically Acceptable basis, consistent with routine procurement of commercial pharmaceuticals under DLA’s managed supply chain. There are no specified additional clauses, attachments, or special requirements beyond those embedded in the basic contract and standard delivery order structure.